ProMIS Neurosciences (PMN) Competitor Comparison
We are evaluating the key criteria listed to compare ProMIS Neurosciences (PMN) against its competitors in the Biotechnology industry.
Market Capitalization
306 / 368Gross Profits
167 / 278Total Revenue
0 / 300EBITDA
90 / 337Free Cashflow
72 / 352Quick Ratio
302 / 357Earnings per Share
86 / 359Dividend yield
0 / 6Total Cash
304 / 358Performance 3 years
290 / 368Performance 5 years
275 / 368Performance 10 years
257 / 368Linearity 3 years
199 / 368Linearity 5 years
203 / 368Linearity 10 years
150 / 368Total Rank
346 / 368Dividend Rank
244 / 368Valuation Rank
359 / 368Piotroski Rank
106 / 368Muliplier Rank
121 / 368Gross Profits - PMN ranking 167 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.